A Clearfield man was given a fatal cancer diagnosis nearly a year ago \u2014 though, he s been able to stave off death due to treatment for a rare disease discovered earlier by genetic testing.
Drs Kitko and Patel discuss graft-versus-host disease recognition, treatment selection, and ongoing research with novel agents and biomarkers of response.
Srinivas K. Tantravahi, MBBS, MRCP, discusses the preliminary efficacy of selinexor in combination with ruxolitinib in patients with JAK inhibitor–naive myelofibrosis, as seen in the phase 1 XPORT-MF-034 trial.